Table 2.
Persistence of SARS-CoV-2 in children
Country | Sample size | Age | Sex | Diagnosis of COVID-19 complication | Baseline severity of COVID-19 | Biopsy or autopsy | Organs analysed | Findings | Time between the acute infection and biopsy or autopsy | Evidence of virus, viral fragments, or antibodies | |
---|---|---|---|---|---|---|---|---|---|---|---|
Taweevisit et al (2022)27 | Thailand | 1 | 5 years; 7 months | Male | MIS-C | Asymptomatic | Autopsy | Heart, lungs, kidneys, liver, stomach, intestine, and brain | Viral particles detected in heart, kidney, and intestine | 2 months and 15 days | Viral RNA |
Dolhnikoff et al (2020)28 | Brazil | 1 | 11 years | Female | MIS-C | Not reported | Autopsy | Heart, lungs, kidney, liver, stomach, brain, inguinal lymph nodes, muscle, and skin | SARS-CoV-2 RNA detected on a post-mortem nasopharyngeal swab and in cardiac and pulmonary tissues by RT-PCR by use of primers and probes set for E (envelope) gene 2 | Not reported | Viral RNA |
Duarte-Neto et al (2021)26 | Brazil | 3 | 8–12 years | 2 female, 1 male | MIS-C | Not reported | Autopsy | Lung, heart, liver, kidneys, spleen, brain, bone marrow, colon, skin, and muscle | RT-PCR for SARS-CoV-2 positive in lung and heart of patient 1; intestine and parotid of patient 2; viral particle detected in cardiomyocytes of patient 3 | Not reported | Viral RNA |
Mayordomo-Colunga et al (2022)29 | Spain | 1 | 12 years | Male | MIS-C | Asymptomatc | Autopsy | Intestine, heart, lungs, and pericecal lymph nod | Spike protein detected by immunofluorescence in intestine | 6 weeks | Spike protein |
Sigal et al (2022)30 | USA | 3 | Not reported | Not reported | MIS-C | Not reported | Blood sample | Blood | Antigens detected in 3 (5·7%) of 53 samples | >2 weeks | Antigen N or S |
Arostegui et al (2022)31 | USA | 1 | 11 years | Female | Long COVID | Mild | Colonscopy | Intestine | SARS-CoV-2 nucleocapsid proteins detected in the intestinal lamina propria | 3 months | SARS-CoV-2 nucleocapsid proteins |
Scottoni et al (2022)32 | Multinational | 2 | 1 month; 5 months | 1 male, 1 female | Intussusception | Mild | Biopsy | Lymph node and Ileum | Immunofluorescence staining revealed the presence of SARS-CoV-2 in both the mesenteric lymph node from patient 1 and ileum from patient 2 | 5 days | Virus |
Colmenero et al (2020)33 | Spain | 7 | 11–17 years | 4 males; 3 females | Chiblains | Asymptomatic or mild | Biopsy | Skin of the toes | Cytoplasmic granular positivity for SARS-CoV-2 spike protein shown in endothelial cells of the capillary and postcapillary venules of the upper dermis, and in epithelial cells of the secretory portion of eccrine units in all cases | 4–30 days | Spike protein |
Miura et al (2022)35 | Brazil | 48 | Not reported | Not reported | Asymptomatic | Asymptomatic | Tonsillectomy | Tonsils and adenoids | SARS-CoV-2 genome detection rate was 20% in the tonsils, 16·27% in the adenoids, 10·41% of nasal cytobrushes, and 6·25% of nasal washes. IHC confirmed the presence of SARS-CoV-2 nucleoprotein in 15 of 16 positive tonsils samples, both in epithelium and lymphoid compartment | Not reported | Viral RNA |
Araùjo et al (2021)34 | Brazil | 1 | 17 years | Female | Guillain-Barrè syndrome | Mild | CSF | CSF | SARS-CoV-2 RNA in CSF | 8 days | Viral RNA |
Xu et al (2022)36 | USA | 110 | 1·7–21 years | Female | No complication | Asymptomatic or mild | Biopsy | Tonsils and adenoids | Pharyngeal tissues from COVID-19-convalescent children showed persistent expansion of germinal centre and antiviral lymphocyte populations associated with interferon-γ-type responses, particularly in the adenoids, and viral RNA in both tissues | 25–303 days | Viral RNA |
IHC=immunohistochemistry. MIS-C=multisystem inflammatory syndrome in children. CSF= cerebrospinal fluid.